Health Systems

September 16th 2025

Providers also have concerns about being able to stock certain medications, which would have a negative impact on their patients, according the Avalere Health survey.

September 12th 2025

Jennifer Walsh of George Washington University’s School of Nursing warned that limiting COVID-19 vaccine approvals to older adults and high-risk groups could heighten disparities, reduce access and leave vulnerable populations at greater risk of infection and severe outcomes.

September 10th 2025

Two separate analyses in Health Affairs find the One Big Beautiful Bill creates a loophole that exempts or delays orphan drugs — many of them blockbuster drugs that generate billions of dollars in sales — from price negotiations.

September 9th 2025

ICER’s comparative effectiveness and value review of Wegovy, Zepbound and oral semaglutide finds they are highly effective treatments with significant health benefits, but affordability and long-term management are still unresolved.